Disputations

Morten Luhr at Centre for Molecular Medicine Norway will be defending the thesis “The unfolded protein response and the ATG8 protein family in autophagy” for the degree of Philosophiae doctor.

M.Sc. Morten Luhr at Centre for Molecular Medicine Norway will give a trial lecture on the given topic: “Interplay of autophagy and metabolism in therapy resistance of cancer cells”.

M.Sc. Julia-Kristina Jensen Madsen-Østerbye will be defending the thesis titled, "Studies of hematopoiesis – physiologic and malignant development"

M.Sc. Julia-Kristina Jensen Madsen-Østerbye, NCMM, will give the trial lecture titled, "iPSC derived Haematopoietic Stem Cells - mechanisms and clinical potential"

MSc Shixiong Wang at the Department of Biosciences will be defending the thesis "Investigating signalling and epigenetic factors influencing the functions of transcription factors in breast cancer" for the degree of PhD.

M.Sc. Ellen Østensen at Centre for Molecular Medicine Norway (NCMM) will be defending the thesis "Adrenergic regulation of the Ca2+ homeostasis in the heart - Cardioprotective effects in ischemia-reperfusion injury of targeting the AKAP18γ/δ-PLB interaction" for the degree of PhD.

M.Sc. Bertrand Simon, a joint PhD student from the EMBL-Hamburg and NCMM, will defend his thesis, "Structural and functional regulation of death-associated protein kinases activity by calcium/calmodulin binding" on March 14.

MRes Lisa Gerner at the Centre for Molecular Medicine Norway will be defending the thesis "An Exploration of the Structure and Function of Calcium/calmodulin-dependent kinase kinase 2 (CaMKK2) in Prostate Cancer"  for the degree of PhD.

MSc Theis Sommer at the NCMM will be defending the thesis Biotechnological application and biophysical characterization of the bacterial enzyme Isatin hydrolase AND Structural studies of the regulatory N-terminal domain of the SLC4 bicarbonate transporter family and characterization of a novel zinc bindingfor the degree of PhD.

Doctoral candidate Master of Science Theis Sommer at NCMM will give a trial lecture on the given topic: Intrinsically Disordered Proteins

M.Sc. Nora Valeska Lieske at NCMM will defend her thesis for the degree  philosophiae doctor (ph.d.): Modulation of Adaptive Immune Responses — Studies in infectious diseases and immune disorders.

Doctoral candidate Nora Valeska Lieske at NCMM will have her trial lecture on the topic: Towards a cure for HIV: challenges and possibilities.

M.Sc. Stalin Chellappa Gunasekaran at the Biotechnology Centre of Oslo will defend his theses for the degree philosophiae doctor (ph.d.): Human Regulatory T cells: Suppressive Function and Role in Pancreatic Cancer and Distal Bile Duct Cancer.

Master of Science Tianzhou Zhang at Department of Biosciences/ Biotechnology Centre will defend his dissertation for the PhD degree: Analysis of isoform specific functions of PKD1 and PKD3.

MSc Kristine Moltu at the Department of Biosciences will be defending the thesis Signal network analysis of T cell activation – in human T cells from blood donors and patients with colorectal cancer for the degree of PhD.

M.Sc. Stefan Jörg Barfeld at the Centre for Molecular Medicine Norway and the Department of Biosciences, Faculty of Mathematics and Natural Sciences will be defending the thesis The transcriptional role of c-Myc in prostate cancer for the degree of PhD. The event will take place on October 23, Kristine Bonnevie Building at 13:15.

The trial lecture entitled "Cancer Immunotherapy - strategies, mechanisms and challenges" takes place on October 23 at 10:15, Nucleus, Bikuben, Kristine Bonnevie Building.

On Tuesday the 24th of February Tanima SenGupta from Hilde Nilsen’s research group will defend her PhD thesis: Chemical genetic studies in Caenorhabditis elegans reveal genome dynamics as key factor in response to chemotherapeutic agents.

Cand.scient Kaare Bjerregaard-Andersen at the Centre for Molecular Medicine (NCMM) and the Department of Biosciences, Faculty of Mathematics and Natural Sciences  will defend the title of his thesis for the Ph.D. degree (philosophiae doctor): Structural and biophysical studies of the mammalian Na⁺ dependent Cl^--HCO₃-exchanger NCBE and the bacterial enzyme isatin hydrolase.

The event will take place in Auditorium 3, Kristine Bonnevie, on 30 June at 13:15.

The trial lecture entitled "Intrinsically disordered proteins and structure/function relationships - reaching into translational medicine" takes place 30 June at 9:15, Auditorium 3, Kristine Bonnevie.

Master of Science Harri M. Itkonen at the Centre for Molecular Medicine (NCMM) and the Department of Biosciences, Faculty of Mathematics and Natural Sciences  will defend the title of his thesis for the Ph.D. degree (philosophiae doctor): Glycosylation in prostate cancer. The event will take place in Forum Auditorium, Forskningsparken, on May 9 at 13:15.

The trial lecture entitled "Metabolic transformation during tumorigenesis" takes place 9 May at 10:15, Auditorium Kino, Forskningsparken.

Master of Science Harri M. Itkonen at the Centre for Molecular Medicine (NCMM) and the Department of Biosciences, Faculty of Mathematics and Natural Sciences  will defend the title of his thesis for the Ph.D. degree (philosophiae doctor): Glycosylation in prostate cancer. The event will take place in Forum Auditorium, Forskningsparken, on May 9 at 13:15.

The trial lecture entitled "Metabolic transformation during tumorigenesis" takes place 9 May at 10:15, Auditorium Kino, Forskningsparken.

Morten Hagness at the Institute of Clinical Medicine and the Biotechnology Centre of Oslo will defend his thesis for the Ph.D. grade (philosophiae doctor): Liver Transplantation for Colorectal Liver Metastases - Clinical and Immunological Considerations.

M.Sc. Henok Kassahun at the Biotechnology Centre in Oslo will defend his thesis for the Ph.D. grade (philosophiae doctor): Oxidative stress-response pathways maintain fitness of C. elegans DNA repair mutants

M.Sc. Kristina Berg Lorvik at Department of Clinical Medicine will defend her thesis for the ph.d. grade (philosophiae doctor): Inflammation mediated by tumor-specific Th1 or Th2 cells protects against B-cell cancer.